細菌由来タンパク質断片が組織線維症を引き起こす仕組みを解明、抗体治療の可能性も示す(A bacterial protein fragment drives tissue fibrosis, but antibody treatment can help, study finds)

ad

2026-08-31 イリノイ大学アーバナ・シャンペーン校

米イリノイ大学アーバナ・シャンペーン校と三重大学の研究チームは、腸内細菌などが産生するタンパク質断片「コリシン(corisin)」が、肺線維症を直接引き起こす仕組みを明らかにした。患者の肺液からコリシン関連細菌DNAが検出され、抗体でコリシンを除去すると、肺細胞への傷害作用が失われた。コリシンは肺の上皮細胞内に侵入してミトコンドリアに蓄積し、タンパク質の品質管理機構を破壊することで、酸化ストレス、細胞老化、細胞死、瘢痕化を誘発する。さらに、肺でコリシンを持続的に産生するよう遺伝子改変したマウスは自然に肺線維症を発症した。一方、コリシンに結合する抗体を投与すると、線維化の程度や生存率が改善した。研究者らは、コリシンを中和する抗体が肺線維症、さらには他の線維性疾患に対する新しい治療戦略となる可能性を示しているが、臨床応用にはさらなる研究が必要としている。

細菌由来タンパク質断片が組織線維症を引き起こす仕組みを解明、抗体治療の可能性も示す(A bacterial protein fragment drives tissue fibrosis, but antibody treatment can help, study finds)
A sample of mouse lung showing pulmonary fibrosis caused by corisin, a protein fragment produced by bacteria in the microbiome. A new study found that corisin disrupts protein-regulating processes in the mitochondria, causing cell death and tissue fibrosis. Image courtesy Esteban Gabazza

<関連情報>

コリシンはタンパク質恒常性ストレスを誘導し、上皮損傷と肺線維症を引き起こす Corisin induces proteostasis stress to drive epithelial injury and pulmonary fibrosis

Hajime Fujimoto,Taro Yasuma,Corina N. D’Alessandro-Gabazza,Masaaki Toda,Kota Nishihama,Atsuro Takeshita,Valeria Fridman D’Alessandro,Atsushi Tomaru,Haruko Saiki,Tomohito Okano,Yurie Kogue,Tomoko Anoh,Manal A. B. Alhawsawi,Ahmed M. Abdel-Hamid,Brian Imai,Christopher J. Fields,Jessica Teofanovic,Kyle Leistikow,Ryoichi Ono,Tetsuya Nosaka,Hidetoshi Yamazaki,Daishi Yamakawa,Yasuko K. Bando,Fuminori Sugihara,… Esteban C. Gabazza
Nature Communications  Published:01 August 2026
DOI:https://doi.org/10.1038/s41467-026-76162-7

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease lacking clarity on the mechanisms linking epithelial injury to fibrotic remodeling. Here, we identify the microbiota-derived corisin as a potent, multifaceted driver of epithelial injury and pulmonary fibrosis. Leveraging targeted DNA sequencing of bronchoalveolar lavage fluid, we provide the first sequence-based identification of corisin in IPF patients and show that functional depletion of native corisin from patient bronchoalveolar lavage fluid abolishes its proapoptotic activity in alveolar epithelial cells. Synthetic corisin readily penetrates epithelial cells, localizes to mitochondria, and induces apoptosis, cellular senescence, and epithelial–mesenchymal transition, effects validated by single-cell transcriptomic analysis. High-throughput protein-interaction screening identifies the ubiquitin–proteasome system as the primary target, demonstrating that corisin enhances proteasome activity and disrupts epithelial proteostasis. Intracellular expression of native corisin recapitulates these cellular pathologies at concentrations relevant to human disease, confirming its high intrinsic potency. Most critically, transgenic mice constitutively expressing native corisin develop spontaneous, progressive pulmonary fibrosis and exhibit exacerbated injury and increased mortality following bleomycin challenge. Collectively, our findings establish corisin as a microbiota-derived effector that directly couples the collapse of epithelial proteostasis to multimechanistic cell-fate dysregulation and fibrotic remodeling, thereby defining a potent and causal microbial–epithelial axis in the pathogenesis of IPF.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました